Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2.
Heylen
R
R
Pharmacy Department, University College London Hospitals (NHS) Trust, Middlesex Hospital Site, UK.
Miller
R
R
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D019469:Indinavir / Q000009:adverse effects / Q000493:pharmacokinetics; D019259:Lamivudine / Q000009:adverse effects / Q000493:pharmacokinetics; D019438:Ritonavir / Q000009:adverse effects / Q000493:pharmacokinetics; D019258:Saquinavir / Q000009:adverse effects / Q000493:pharmacokinetics
D019380:Anti-HIV Agents; D019259:Lamivudine; D019469:Indinavir; D019258:Saquinavir; D019438:Ritonavir